To assess the pharmacokinetics, safety, and tolerability of AZD8233 in participants with Chronic Kidney Disease (CKD), end stage renal disease (ESRD) and healthy participants.

Trial Identifier:	D7990C00007
Sponsor:	AstraZeneca
Collaborator:	PAREXEL International
NCTID::	NCT05065463
Start Date:	August 2022
Primary Completion Date:	November 2022
Study Completion Date:	November 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Polish Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
PL	Gdańsk, PL, 80-952

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.